Advanced Filters
noise

allergy Clinical Trials

A listing of allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 388 clinical trials
P Paulien Verscheure, MSc

Impacts of Nitrogen Deposition in the Natural Environment on Pollen Allergy in Belgium

The investigators want to study the effect of environmental nitrogen enrichment on the allergy burden in pollen-sensitized subjects.

18 years of age All Phase N/A
J Jun Yan, M.D.,Ph.D

Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer

The purpose of this study is to investigate whether chemotherapy guided by patient-derived tumor organoid drug test can improve the outcomes of stage IV colorectal cancer.

18 - 70 years of age All Phase N/A
M Miriam Lense

Reciprocal Imitation Training and Musical Rhythm Sensitivity in Autistic Toddlers

The primary goal of this study is to examine rhythm sensitivity as a predictor of response to naturalistic developmental behavioral intervention (NDBIs) in autistic toddlers. Toddlers receive either Reciprocal Imitation Training (RIT), an evidence-based NDBI that supports children's imitation and social communication skills, or a music-enhanced version of RIT. Throughout …

18 - 36 years of age All Phase N/A
P Pasquale Mansueto, MD

Response to Different Wheat Genotypes in Not-celiac Wheat Sensitivity

Non-celiac gluten sensitivity (NCGS) is a condition where intestinal and extraintestinal symptoms are triggered by gluten ingestion in the absence of celiac disease and wheat allergy. Despite the great interest in NCGS, much remains unknown about the pathogenesis. Some studies seem to suggest that wheat components other than gluten (i.e. …

18 - 65 years of age All Phase N/A
Y Yinyan Wang, MD and PhD

Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas

The MRI data were collected from patients with gliomas before surgery, 2 weeks before initiating radiochemotherapy, 1 month after completing the radiotherapy (for lower-grade gliomas, LGG), or 4 and 10 months after completing the radiochemotherapy (for high-grade gliomas, HGG). Radiochemotherapy sensitivity labels were constructed based on the MRI images obtained …

18 years of age All Phase N/A
L Liane Beaudette

Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety

Protocols for Oral Immunotherapy (OIT) for the main food allergens have been recently incorporated in clinical practice for food allergies and their clinical benefits have been acknowledged in European and Canadian official guidelines. There has been some reluctance in both clinicians and patients to implement these therapies, primarily because of …

2 - 40 years of age All Phase N/A
D Dr. Pablo Rodríguez del Río

Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study

This study investigates the efficacy and safety of two different OIT schemes to treat milk and egg allergic children

6 - 16 years of age All Phase 2/3
A Andrew Melson, MD

Comparison Between Spectacles and Contact Lenses

Many people suffer from migraine headaches, some more so than others and a common trigger/complaint is light sensitivity, or photophobia1. Some will go to great lengths to avoid light: a dark room with sunglasses on and blankets over the windows, often missing work/school/social activities, etc. Several ocular conditions are accompanied …

18 years of age All Phase N/A
K Kirsten Bjornlinger, M.D

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

The study is an open label, multi-centre, randomized phase III study. The patients will be randomised in a 1:1 ratio to treatment consisting of Arm A: MD-SBRT in addition to standard treatment Arm B: Standard treatment Study population: Patients with hormone sensitive prostate cancer (HSPC) with oligometastatic disease detected by …

years of age Male Phase 3
J Joshua Plassmeyer

CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer

This is a clinical trial using CPI-0209 in combination with Carboplatin chemotherapy followed by CPI-0209 maintenance in patients with platinum sensitive, recurrent ovarian cancer.

18 years of age Female Phase 1

Simplify language using AI